A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective Disorder

Phase 1 Completed 47 enrolled Alkermes, Inc.

NaSingle-groupOpen-labelTreatment

Summary

The study will determine the safety, tolerability, and pharmacokinetics of aripiprazole lauroxil in adults with schizophrenia or schizoaffective disorder.

Timeline

Start: 2015-12
Primary completion: 2016-06
Completion: 2016-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Aripiprazole Lauroxil	Small molecule	—	Intramuscular

A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective Disorder

Summary

Timeline

Drugs

Indications